EcoDrugPlus

Ensembl ID : YDL042C
Description: -
59 Possible Orthologues:

Title

Ensembl ID : YDL061C
Description: -
67 Possible Orthologues:

Title

Ensembl ID : YDL066W
Description: -
134 Possible Orthologues:

Title

Ensembl ID : YDL075W
Description: -
96 Possible Orthologues:

Title

Ensembl ID : YDL079C
Description: -
141 Possible Orthologues:

Title

Ensembl ID : YDL081C
Description: -
97 Possible Orthologues:

Title

Ensembl ID : YDL082W
Description: -
88 Possible Orthologues:

Title

Ensembl ID : YDL083C
Description: -
136 Possible Orthologues:

Title

Ensembl ID : YDL090C
Description: -
68 Possible Orthologues:

Title

Ensembl ID : YDL097C
Description: -
72 Possible Orthologues:

Title

Ensembl ID : YDL101C
Description: -
48 Possible Orthologues:

Title

Ensembl ID : YDL108W
Description: -
73 Possible Orthologues:

Title

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).